English | Español

Technology/Innovation
+ Technology/Innovation
Carol Ostrow | Sep 18, 2017

Oral chemotherapy generic not deeply discounted, says UNC
+ Community
Carol Ostrow | Sep 18, 2017

University of Pittsburgh scientists to assess sepsis strategies
+ Community
Carol Ostrow | Sep 18, 2017

Wake Forest Baptist Medical Center has new chief financial officer
+ Regulatory
Carol Ostrow | Sep 15, 2017

Kaine warns insurers that Congress won't tolerate "bare counties"
+ Community
Carol Ostrow | Sep 15, 2017

Partnership seeks genetic clues to suicide
+ Community
Carol Ostrow | Sep 14, 2017

Soprano, scientists discuss music's power to heal
+ Technology/Innovation
Carol Ostrow | Sep 14, 2017

Novartis partnering in trial in Mali of new malaria treatment
+ Technology/Innovation
Kacie Whaley | Sep 14, 2017

Novartis says oral fingolimod shows promise in treating children with MS

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'